natgillin/translations-raw huggingface dataset:
Any applications for the licensing of medicines containing castor oil have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo ricinusovo olje, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
Information on the use and licensing of castor oil medicines in EU Member States should be obtained from the relevant national authorities.
Za informacije o uporabi in registraciji zdravil, ki vsebujejo ricinusovo olje, v državah članicah EU se obrnite na pristojni nacionalni organ.
Further information on the HMPC assessment of castor oil medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Dodatne informacije o oceni zdravil, ki vsebujejo ricinusovo olje, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
The HMPC concluded that these castor oil preparations can be used for short term as laxatives for occasional constipation.
Odbor HMPC je zaključil, da se lahko ti pripravki, ki vsebujejo ricinusovo olje, uporabljajo kratkotrajno kot odvajalo pri občasni zaprtosti.
How are castor oil medicines approved in the EU?
Kako so zdravila, ki vsebujejo ricinusovo olje, odobrena v EU?
When ingested, castor oil is broken down into ricinoleic acid which works by reducing absorption of fluid and salts in the small intestine (the upper part of the bowel).
Ob zaužitju se ricinusovo olje razgradi v ricinoleinsko kislino, ki zmanjšuje absorpcijo tekočin in soli v tankem črevesu (zgornjem delu črevesja).
What evidence supports the use of castor oil medicines?
Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo ricinusovo olje?
Other information about castor oil medicines
Druge informacije o zdravilih, ki vsebujejo ricinusovo olje
Detailed instructions on how to take castor oil medicines and who can use them can be found in the package leaflet that comes with the medicine.
Podrobna navodila o jemanju zdravil, ki vsebujejo ricinusovo olje, in o tem, kdo sme ta zdravila jemati, so na voljo v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
What are the risks associated with castor oil medicines?
Kakšna tveganja so povezana z zdravili, ki vsebujejo ricinusovo olje?
For more information about treatment with castor oil medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Za več informacij o zdravljenju z zdravili, ki vsebujejo ricinusovo olje, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
For practical information about using castor oil medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
In addition, castor oil stimulates movement in the intestines which will help to pass the stools.
Poleg tega ricinusovo olje spodbuja gibanje črevesa, zato je odvajanje blata lažje.
Member States when evaluating applications for the licensing of herbal medicines containing castor oil.
Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo ricinusovo olje.
Side effects have been reported with castor oil.
Pri uporabi ricinusovega olja so poročali o neželenih učinkih.
MA (EU) number (Invented) name Strength Pharmaceutical form Route of administration Immediate Packaging Pack size EU/1/08/498/002 Thymanax
Jakost Farmacevtska oblika Pot uporabe
Conclusions presented by the European Medicines Agency on:
Sklepne ugotovitve, ki jih je predstavila Evropska agencija za zdravila, o:
<Similarity>
<podobnosti>
<Derogation>
<odstopanju>
<the holder of the marketing authorisation for <authorised orphan medicinal product> has given his consent to the applicant.>
<imetnik dovoljenja za promet z <odobrenim zdravilom siroto> je dal svoje soglasje predlagatelju.>
<one-year <marketing protection><data exclusivity>>
<enoletni <tržni zaščiti> <ekskluzivnosti podatkov>>
Conditional marketing authorisation
pridobitvi pogojnega dovoljenja za promet z zdravilom
CONCLUSIONS ON THE GRANTING OF THE CONDITIONAL MARKETING AUTHORISATION AND <SIMILARITY AND DEROGATION> <AND> < THE REQUEST FOR ONE-YEAR <MARKETING PROTECTION> <DATA EXCLUSIVITY>> PRESENTED BY THE EUROPEAN MEDICINES AGENCY
SKLEPNE UGOTOVITVE O PRIDOBITVI POGOJNEGA DOVOLJENJA ZA PROMET Z ZDRAVILOM TER <PODOBNOSTI IN ODSTOPANJU> <IN> <ZAHTEVKU ZA ENOLETNO <TRŽNO ZAŠČITO> <EKSKLUZIVNOST PODATKOV>>, KI JIH JE PREDSTAVILA EVROPSKA AGENCIJA ZA ZDRAVILA
<the holder of the marketing authorisation for <authorised orphan medicinal product> is unable to supply sufficient quantities of the medicinal product> <and>
<imetnik dovoljenja za promet z <odobrenim zdravilom siroto> ni sposoben dobavljati zadostnih količin zdravila>; <in>
[For Art 14(11)] <The CHMP reviewed the data submitted by the Marketing Authorisation Holder, taking into account the provisions of Article 14(11) of Regulation (EC) No 726/2004, and considers that the new therapeutic indication brings significant clinical benefit in comparison with existing therapies as further explained in the European Public Assessment Report.
[For Art 14(11)] <Odbor za zdravila za uporabo v humani medicini (CHMP) je pregledal podatke, ki jih je predložil imetnik dovoljenja za promet z zdravilom, pri čemer je upošteval določbe člena 14(11) Uredbe (ES) št. 726/2004, in meni, da nova terapevtska indikacija prinaša pomembno klinično korist v primerjavi z obstoječimi terapijami, kot je podrobneje razloženo v evropskem javnem poročilu o oceni zdravila.>
<the applicant could establish in the application that the medicinal product, although similar to <authorised orphan medicinal product>, is safer, more effective or otherwise clinically superior (as defined in Article 3 of Commission Regulation (EC) No. 847/2000) for the same therapeutic indication> <and>
<predlagatelj je v svoji vlogi lahko utemeljil, da je zdravilo, čeprav je podobno <odobrenemu zdravilu siroti>, varnejše, učinkovitejše ali kako drugače klinično boljše (kot je opredeljeno v členu 3 Uredbe Komisije (ES) št. 847/2000) za isto terapevtsko indikacijo>; <in>
<The CHMP is of the opinion that pursuant to Article 8 of Regulation (EC) No. 141/2000 and <Article 3 of Commission Regulation (EC) No 847/2000> [only for the superiority derogation] the following derogation
 laid down in Article 8.3 of the same Regulation apply(ies) as further explained in European Public Assessment Report :
<Odbor za zdravila za uporabo v humani medicini (CHMP) meni, da v skladu s členom 8 Uredbe (ES) št. 141/2000 in <členom 3 Uredbe Komisije (ES) št. 847/2000> [only for the superiority derogation] velja(-jo) naslednje(-a) odstopanje(-a), določeno(-a) v členu 8(3) iste uredbe, kot je podrobneje razloženo v evropskem javnem poročilu o oceni zdravila:
The CHMP having considered the application is of the opinion that the risk-benefit balance is favourable to recommend the granting of the conditional marketing authorisation as further explained in the European Public Assessment Report.
Odbor za zdravila za uporabo v humani medicini (CHMP) po obravnavi vloge meni, da je razmerje med tveganji in koristmi ugodno, da lahko priporoči izdajo pogojnega dovoljenja za promet z zdravilom, kot je podrobneje razloženo v evropskem javnem poročilu o oceni zdravila.
[Art 10(5)] <The CHMP reviewed the data submitted by the Marketing Authorisation Holder, taking into account the provisions of Article 10(5) of Directive 2001/83/EC, and considers that <the <pre-clinical tests> <and> <clinical studies> carried out in relation to the new indication were significant as further explained in the European Public Assessment Report.
[Art 10(5)] <Odbor za zdravila za uporabo v humani medicini (CHMP) je pregledal podatke, ki jih je predložil imetnik dovoljenja za promet z zdravilom, pri čemer je upošteval določbe člena 10(5) Direktive 2001/83/ES, in meni, da so bili(-e) <predklinični testi> <in> <klinične študije>, ki so bili(-e) izvedeni(-e) v zvezi z novo indikacijo pomembni(-e), kot je podrobneje razloženo v evropskem javnem poročilu o oceni zdravila.>
<The CHMP is of the opinion that <name of product> is similar to authorised orphan medicinal products within the meaning of Article 3 of Commission Regulation (EC) No. 847/2000 as further explained in the European Public Assessment Report.
<Odbor za zdravila za uporabo v humani medicini (CHMP) meni, da je zdravilo <ime zdravila> podobno odobrenim zdravilom sirotam v smislu opredelitve iz člena 3 Uredbe Komisije (ES) št. 847/2000, kot je podrobneje razloženo v evropskem javnem poročilu o oceni zdravila.>
Hungary ratiopharm Hungária Kereskedelmi Kft. Uzsoki u. 36/a
Madžarska ratiopharm Hungária Kereskedelmi Kft. Uzsoki u. 36/a
Laboratórios Vitória, S.A. Rua Elias Garcia, 28 - Venda Nova
Portugalska Laboratórios Vitória, S.A. Rua Elias Garcia, 28 - Venda Nova
Laboratório B. A. Farma, Lda.
Portugalska Laboratório B. A. Farma, Lda.
Austria ratiopharm Arzneimittel VertriebsGmbH Albert-Schweitzer-Gasse 3 1140 Vienna
Avstrija ratiopharm Arzneimittel VertriebsGmbH Albert-Schweitzer-Gasse 3 1140 Vienna
Pharmaswiss Eesti OÜ Tammsaare tee 47 11316 Tallinn Estonia
Pharmaswiss Eesti OÜ Tammsaare tee 47 11316 Tallinn Estonia dikofenak
The Netherlands Wise Pharmaceuticals Ltd. Hamwells Business Park Unit No. 7, Hardicker Street M19 2RB Manchester
Nizozemska Wise Pharmaceuticals Ltd. Hamwells Business Park Unit No. 7, Hardicker Street M19 2RB Manchester
Annex I List of the names, pharmaceutical forms, strengths of the medicinal products, routes of administration, marketing authorisation holders in the Member States
Priloga I Seznam imen, farmacevtskih oblik, jakosti zdravil, poti uporabe zdravila,
Laboratoires Genevrier 280, rue de Goa Les Trois Moulins - Parc de Sophia Antipolis 06600 Antibes France
Laboratoires Genevrier 280, rue de Goa Les Trois Moulins - Parc de Sophia Antipolis 06600 Antibes France epolaminijev diklofenakat
Pfizer Enterprises SARL Round-Point du Kirchberg 51, Avenue J.F.Kennedy L-1855 Luxembourg Luxembourg
Pfizer Enterprises SARL Round-Point du Kirchberg 51, Avenue J.F.Kennedy L-1855 Luxembourg Luxembourg dikofenak misoprostol
Zona Industrial do Lagedo 3465-157 Santiago de Besteiros
Zona Industrial do Lagedo 3465-157 Santiago de
Novartis Consumer Health Produtos Farmacêuticos e Nutrição, Lda.
Portugalska Novartis Consumer Health Produtos Farmacêuticos e Nutrição, Lda.
The Netherlands Manston Pharma Limited 3 Montpelier Avenue, Bexley DA5 3AP Kent
Nizozemska Manston Pharma Limited 3 Montpelier Avenue, Bexley DA5 3AP Kent
Vetenskapsvägen 10 191 90 Sollentuna Sweden
Vetenskapsvägen 10 191 90 Sollentuna Sweden diklofenak misoprostol
Rua do Centro Empresarial Edifício 8, Quinta da Beloura 2710-444 Sintra Portugal
Rua do Centro Empresarial Edifício 8, Quinta da Beloura 2710-444 Sintra
Laboratório Normal - Produtos Farmacêuticos, Lda.
Portugalska Laboratório Normal - Produtos Farmacêuticos, Lda.
S.C. TERAPIA S.A. Str. Fabricii nr. 124 Cluj-Napoca 400 632 România
Str. Fabricii nr. 124 Cluj-Napoca 400 632 România
Pfizer AS Lilleakerveien 2B 1324 Lysaker Norway
Pfizer AS Lilleakerveien 2B 1324 Lysaker Norway natrijev diklofenakat misoprostol
97-107 Uxbridge Road London W5 5TL
97-107 Uxbridge Road London W5 5TL United Kingdom kalijev diklofenakat
Scandinavian Regulatory Services, AB Svardvagen 3B Stockholm SE-182 33 Sweden
Scandinavian Regulatory Services, AB Svardvagen 3B Stockholm SE-182 33 Sweden kalijev diklofenakat
Pfizer ApS Lautrupvang 8 DK-2750 Ballerup Denmark
Pfizer ApS Lautrupvang 8 DK-2750 Ballerup Denmark diklofenak misoprostol
Pfizer Hellas A.E. Messoghion Ave. 243 Neo Psychiko 15451 Greece
Pfizer Hellas A.E. Messoghion Ave. 243 Neo Psychiko 15451 Greece natrijev diklofenakat misoprostol
Rua do Centro Empresarial, Edf 8, Quinta da Beloura 2710-693 Sintra Portugal
Rua do Centro Empresarial, Edf 8, Quinta da Beloura 2710-693 Sintra
de Europa, 20 B Parque Empresarial La Moraleja 28108 Alcobendas (Madrid) Spain
de Europa, 20 B Parque Empresarial La Moraleja
Via Cassia Nord 351 Darvia - 53014 Siena Italy
Via Cassia Nord 351 Darvia - 53014 Siena Italy natrijev diklofenakat ALGOSENAC
Confar - Consórcio Farmacêutico, Lda.
Portugalska Confar - Consórcio Farmacêutico, Lda.
Novartis Norge AS Nydalen Alle 37 A 0484 Oslo Norway
Novartis Norge AS Nydalen Alle 37 A 0484 Oslo Norway kalijev diklofenakat
Pfizer Europe MA EEIG Ramsgate Road Kent, Sandwich CT13 9NJ United Kingdom
Pfizer Europe MA EEIG Ramsgate Road Kent, Sandwich CT13 9NJ United Kingdom diklofenak misoprostol
Park View, Riverside Way Watchmoor Park, Camberley Surrey GU15 3YL United Kingdom
Park View, Riverside Way Watchmoor Park, Camberley Surrey GU15 3YL United Kingdom kalijev diklofenakat
TRATUL 120 mg 120mg
TRATUL 120 mg 120mg svečka rektalna uporaba
CostanzaFarma srl Via Taranto 4 20142 Milano Italy
CostanzaFarma srl Via Taranto 4 20142 Milano Italy natrijev diklofenakat DEALGIC
Granules for oral suspension
zrnca za peroralno suspenzijo
HELP ABEE Valaoritou 10 Metamorfosi Attikis, 14452 Greece
HELP ABEE Valaoritou 10 Metamorfosi Attikis, 14452 Greece natrijev diklofenakat VURDON
Kent CT13 9NJ United Kingdom
Kent CT13 9NJ United Kingdom diklofenak misoprostol
FLECTOR RAPID 50 mg granulátum
FLECTOR RAPID 50 mg granulátum zrnca
Novartis Farma - Produtos Farmacêuticos, S.A.
Portugalska Novartis Farma - Produtos Farmacêuticos, S.A.
NOVARTIS SANTE FAMILIALE 14, boulevard Richelieu 92500 Rueil-Malmaison France
NOVARTIS SANTE FAMILIALE 14, boulevard Richelieu 92500 Rueil-Malmaison France kalijev diklofenakat
Campo de Besteiros 3465-051 Santiago de Besteiros
3465-051 Santiago de
Diclovit hard capsules
Diclovit hard capsules kapsula, trda
Via Sette Santi 3, Firenze 50131- Italy
Via Sette Santi 3, Firenze 50131- Italy natrijev diklofenakat FLOGOFENAC
IS-220 Hafnarfjördur Iceæand
IS-220 Hafnarfjördur Iceæand kalijev diklofenakat
Actavis A/S Ornegardsvej 16 2820 Gentofte Denmark
Actavis A/S Ornegardsvej 16 2820 Gentofte Denmark kalijev diklofenakat
Via Cesarea, 11/10 Genova - 16121 Italy
Via Cesarea, 11/10 Genova - 16121 Italy natrijev diklofenakat DICLOFENAC ALMUS
89340 Leipheim Germany
89340 Leipheim Germany kalijev diklofenakat
182 12 Danderyd Sweden
182 12 Danderyd Sweden kalijev diklofenakat
Prolonged-release tablet hameln pharma plus gmbh Langes Feld 13
Nemčija hameln pharma plus gmbh Langes Feld 13
Via Isonzo 71 Latina 04100 Italy
Via Isonzo 71 Latina 04100 Italy natrijev diklofenakat misoprostol
Labesfal - Laboratórios Almiro S.A.
Portugalska Labesfal - Laboratórios Almiro S.A.
United Kingdom Co-Pharma Limited Unit 4, Metro Centre Tolpits Lane, Watford Hertfordshire WD18 9SS United Kingdom
Co-Pharma Limited Unit 4, Metro Centre Tolpits Lane, Watford Hertfordshire WD18 9SS United Kingdom natrijev diklofenakat Diclo-SR 75
61118 Bad Vilbel Germany
61118 Bad Vilbel Germany kalijev diklofenakat
Czech Republic Mepha Investigação, Desenvolvimento e Fabricação Farmacêutica, Lda.
Portugalska Mepha Investigação, Desenvolvimento e Fabricação Farmacêutica, Lda.
BROS EPE Avgis & Gallinis 15 N. Kifissia, 14564 Greece
BROS EPE Avgis & Gallinis 15 N. Kifissia, 14564 Greece natrijev diklofenakat EVINOPON
Diclofenac sodium DICLOFENACO ALDO-UNION comprimidos EFG
Spain natrijev diklofenakat DICLOFENACO ALDO-UNION comprimidos EFG
Pinewood Laboratories Ltd (T/A Pinewood Heathcare) Ballymacarbry Clonmel, Co. Tipperary Ireland
Pinewood Laboratories Ltd (T/A Pinewood Heathcare) Ballymacarbry Clonmel, Co. Tipperary Ireland natrijev diklofenakat Diclo 75mg prolonged release tablets.
The Netherlands Actavis Group PTC ehf Reykjavikurvegi 76-78
Nizozemska Actavis Group PTC ehf Reykjavikurvegi 76-78
Diclofenac potassium Diclofenacratiopharm Lösung bei Migräne
Diclofenacratiopharm Lösung bei Migräne
Luxembourg Socobom S.A Avenue Louise 149 b24 B-1050 Bruxelles Belgium
Luksemburg Socobom S.A Avenue Louise 149 b24 B-1050 Bruxelles Belgium natrijev diklofenakat Polyflam-50
The Netherlands Alfa Wassermann S.p.A.
Nizozemska Alfa Wassermann S.p.A.
02631 Espoo Finland
02631 Espoo Finland kalijev diklofenakat
Olfen 100 mg trde kapsule s podaljšanim sproščanjem
Olfen 100 mg trde kapsule s podaljšanim sproščanjem kapsula s podaljšanim sproščanjem, trda
Pharmacia GmbH Linkstrasse 10 10785 Berlin Germany
Pharmacia GmbH Linkstrasse 10 10785 Berlin Germany natrijev diklofenakat misoprostol
The Netherlands Apotex Europe B.V. Darwinweg 20
Nizozemska Apotex Europe B.V.
Via Pavia, 6 Milano - 20136 Italy
Via Pavia, 6 Milano - 20136 Italy natrijev diklofenakat DICLOFAN
12th Km National Highway No 1, Metamorfosi Attikis 144 51 Greece
12th Km National Highway No 1, Metamorfosi Attikis 144 51 Greece kalijev diklofenakat
110 B 20097 Hamburg Germany
110 B 20097 Hamburg Germany natrijev diklofenakat DICLOWAL 50
FI-02200 Espoo Finland
FI-02200 Espoo Finland kalijev diklofenakat
Controlled release capsule
kapsula z nadzorovanim sproščanjem
Rectal use betapharm Arzneimittel GmbH Kobelweg 95
Nemčija betapharm Arzneimittel GmbH Kobelweg 95
Naklofen SR 100 mg tablete s podaljšanim sproščanjem
Naklofen SR 100 mg tablete s podaljšanim sproščanjem tableta s podaljšanim sproščanjem
T & D Pharma GmbH Kleine Knopheide 4 32657 Lemgo Germany
T & D Pharma GmbH Kleine Knopheide 4 32657 Lemgo Germany natrijev diklofenakat Allvoran SF
12,5mg Tablet
12,5mg tableta
Na Pankráci 1724/129 140 00 Praha 4 - Nusle Czech Republic
Na Pankraci 1724/129 140 00 Praha 4
Capsule, hard Oral use
kapsula, mehka peroralna uporaba
Diclofenac sodium VOLTAREN DOLO FILM COATED
Greece natrijev diklofenakat VOLTAREN DOLO FILM COATED
Starogard Gdański 83-200 Poland
Starogard Gdański 83-200 Poland natrijev diklofenakat Majamil PPH
Estrada Marco do GriloZemouto
Portugalska Alter, S.A. Estrada Marco do GriloZemouto
Cipla (UK) Ltd The Old Post House Heath Road,Weybridge Surrey KT138TS United Kingdom
Cipla (UK) Ltd The Old Post House Heath Road,Weybridge Surrey KT138TS United Kingdom natrijev diklofenakat Diclogen 100 mg suppositories svečka rektalna uporaba
Diclofenac sodium Voltarol Retard 75 mg Film-coated
United Kingdom natrijev diklofenakat Voltarol Retard 75 mg Film-coated
Modified- release capsule, hard
modified- release kapsula, trda
Diclofenac epolamine FLECTOR 25 mg, granulés pour solution buvable en sachet-dose
FLECTOR 25 mg, granulés pour solution buvable en sachet-dose zrnca za peroralno raztopino
183 11 Täby Sweden
183 11 Täby Sweden kalijev diklofenakat
Largo Donegani 4/a Novara - 28100 Italy
Largo Donegani 4/a Novara - 28100 Italy natrijev diklofenakat FENADOL
DICLOFENAC DUO PHARMAVIT 75 mg kemény kapszula
DICLOFENAC DUO PHARMAVIT 75 mg kemény kapszula kapsula, trda
TAD Pharma GmbH Heinz-Lohmann-Str. 5 27472 Cuxhaven Germany
TAD Pharma GmbH Heinz-Lohmann-Str. 5 27472 Cuxhaven Germany natrijev diklofenakat Allvoran 25mg
Prolonged-release tablet sigapharm GmbH Temmlerstr.
Nemčija sigapharm GmbH Temmlerstr.
Naklofen duo 75 mg trde kapsule
Naklofen duo 75 mg trde kapsule kapsula, trda
B-1348 Louvain-la-Neuve Belgium
B-1348 Louvain-la-Neuve Belgium natrijev diklofenakat Motifene-75
Diclofenac sodium Sandoz Ltd Diclovol SR Modified Release
Camberley, GUI16 7SR United Kingdom natrijev diklofenakat Sandoz Ltd Diclovol SR Modified Release
Diclofenacum natricum Diclorapid 75 mg gastro-resistant capsules, hard
Latvia natrijev diklofenakat Diclorapid 75 mg gastro-resistant capsules, hard gastrorezistentna kapsula, trda
The Netherlands Disphar International B.V. Winkelskamp 6
Nizozemska Disphar International B.V.
Diclofenac epolamine FLECTOR 50 mg, granulés pour solution buvable en sachet-dose
FLECTOR 50 mg, granulés pour solution buvable en sachet-dose zrnca za peroralno raztopino
Diclofenac sodium Voltarol 12.5mg Suppositories
United Kingdom natrijev diklofenakat Voltarol 12.5mg Suppositories
DK-2100 Københawn Ø Denmark
DK-2100 Københawn Ø Denmark kalijev diklofenakat
Diclofenac sodium ALMIRAL GASTRORESISTANT TABLET
Cyprus natrijev diklofenakat ALMIRAL GASTRORESISTANT TABLET
The Netherlands Novartis Pharma B.V. Raapopseweg 1
Nizozemska Novartis Pharma B.V.
DicloJet 75 mg trde gastrorezistentne kapsule
DicloJet 75 mg trde gastrorezistentne kapsule gastrorezistentna kapsula, trda
Gastro-resistant capsule, hard
gastrorezistentna kapsula, trda
Diclofenac sodium Voltarol Retard 100 mg Film-coated
United Kingdom natrijev diklofenakat Voltarol Retard 100 mg Film-coated
Diclofenac sodium Dolpasse 75 mgInfusionslösung
Austria natrijev diklofenakat Dolpasse 75 mgInfusionslösung
12,5mg Capsule, soft
12,5mg kapsula, mehka peroralna uporaba
Diclofenac sodium DOLOTREN DISPERSABLE comprimidos
Spain natrijev diklofenakat DOLOTREN DISPERSABLE comprimidos orodisperzibilna tableta
Diclo Duo 75 mg trde gastrorezistentne kapsule
Diclo Duo 75 mg trde gastrorezistentne kapsule gastrorezistentna kapsula, trda
Arthrotec 75, tabletten 75 mg
Arthrotec 75, tabletten 75 mg tableta s prirejenim sproščanjem
Diclofenac sodium Diclofenac "Sandoz" retard 100 mg
Austria natrijev diklofenakat Diclofenac "Sandoz" retard 100 mg
EG S.p.a Via Scarlatti, 31 Milano - 20124 Italy
EG S.p.a Via Scarlatti, 31 Milano - 20124 Italy natrijev diklofenakat DICLOFENAC EG 50mg
Astellas Pharma GmbH Linzer Straße 221/E02 1140 Vienna Austria
Astellas Pharma GmbH Linzer Straße 221/E02 1140 Vienna Austria natrijev diklofenakat Deflamat 75 mgAmpullen
Diclofenac sodium RHEUMAVEK
Greece natrijev diklofenakat RHEUMAVEK
Diclofenac sodium ALMIRAL SUPPOSITORY
Cyprus natrijev diklofenakat ALMIRAL SUPPOSITORY
Diclofenac sodium DIFENE DUAL CAPSULE 75MG
Cyprus natrijev diklofenakat DIFENE DUAL CAPSULE 75MG
The Netherlands Teva Nederland B.V. Swensweg 5
Nizozemska Teva Nederland B.V.
Naklofen 50 mg svečke
Naklofen 50 mg svečke svečka rektalna uporaba
Via Vittor Pisani, 20 Milano - 20124 Italy
Via Vittor Pisani, 20 Milano - 20124 Italy natrijev diklofenakat DICLOFENAC MYLAN GENERICS
Diclofenac sodium Diclo-CT 100 mg Supp.
Germany natrijev diklofenakat Diclo-CT 100 mg Supp.
Diclofenac sodium Diclo-CT 50mg Supp.
Germany natrijev diklofenakat Diclo-CT 50mg Supp.
FLECTOR DOLORE 25mg
FLECTOR DOLORE 25mg zrnca za peroralno raztopino
Diclofenac potassium Voltaren Express 12,5mg Capsule, soft
Germany natrijev diklofenakat Voltaren Express 12,5mg kapsula, mehka peroralna uporaba
Diclofenac Ratiopharm 100 mg Supositórios
Diclofenac Ratiopharm 100 mg Supositórios svečka rektalna uporaba
Diclofenac sodium Orphenadrine citrate
Austria natrijev diklofenakat orfenadrinijev citrat
Diclofenac potassium Voltfast Sachets 50 mg Powder for Oral
Voltfast Sachets 50 mg Powder for Oral Solution prašek za peroralno raztopino
Diclofenacum natricum Almiral 25 mg/ml solution for injection and infusion
Cyprus natrijev diklofenakat Almiral 25 mg/ml solution for injection and infusion
Arthrotec 50, tabletten
Arthrotec 50, tabletten tableta s prirejenim sproščanjem
Via Ragazzi del 99 5, Bologna - 40133 Italy
Via Ragazzi del 99 5, Bologna - 40133 Italy natrijev diklofenakat DICLOFENAC ALPHA BIOTECH
Diclofenac sodium Voltarol Ampoules 75mg/3ml, solution for injection
United Kingdom natrijev diklofenakat Voltarol Ampoules 75mg/3ml, solution for injection
United Kingdom Ennogen Pharma Limited Unit G4, Riverside Way Dartford, DA1 5BS
Ennogen Pharma Limited Unit G4, Riverside Way Dartford, DA1 5BS United Kingdom natrijev diklofenakat Enstar XL 100mg Tablets tableta s prirejenim sproščanjem
The Netherlands Centrafarm B.V. Nieuwe Donk 3
Nizozemska Centrafarm B.V.
The Netherlands Mylan B.V. Dieselweg 25
Nizozemska Mylan B.V.
21ST Km National Highway Athens-Lamia, 14565 Greece
21ST Km National Highway Athens-Lamia, 14565 Greece natrijev diklofenakat URIGON
MERCK GesmbH Zimbagasse 5 1147 Vienna Austria
MERCK GesmbH Zimbagasse 5 1147 Vienna Austria natrijev diklofenakat NeurofenacKapseln kapsula, trda